Skip to main content

Table 5 drug toxicity and adverse events

From: Effects of FGFR gene polymorphisms on response and toxicity of cyclophosphamide-epirubicin-docetaxel-based chemotherapy in breast cancer patients

Adverse events

No toxicity (grade0–2)

(N = 109)

Toxicity(grade 3–4)

(N = 102)

Hematological

 Leucopenia

98

95

 Neutropenia

93

90

 Anemia

8

1

 Thrombocytopenia

2

1

Gastrointestinal

 Nausea

47

0

 Vomiting

86

18

 Diarrhea

16

13

Skin rash

6

2

hepatotoxicity

3

0

Renal toxicity

1

0